{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T08:30:11Z","timestamp":1794040211893,"version":"4.8.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11010-021-04216-z","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T04:02:45Z","timestamp":1624852965000},"page":"3935-3950","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Biglycan: an emerging small leucine-rich proteoglycan (SLRP) marker and its clinicopathological significance"],"prefix":"10.1007","volume":"476","author":[{"given":"Sandeep","family":"Appunni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1812-9753","authenticated-orcid":false,"given":"Muni","family":"Rubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkataraghavan","family":"Ramamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuram","family":"Khandelwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"4216_CR1","first-page":"1","volume-title":"Handbook of experimental pharmacology","author":"S Allahverdian","year":"2020","unstructured":"Allahverdian S, Ortega C, Francis GA (2020) Smooth muscle cell-proteoglycan-lipoprotein interactions as drivers of atherosclerosis. Handbook of experimental pharmacology. Springer, Berlin, pp 1\u201324"},{"key":"4216_CR2","doi-asserted-by":"publisher","first-page":"21305","DOI":"10.1074\/jbc.R800020200","volume":"283","author":"L Schaefer","year":"2008","unstructured":"Schaefer L, Iozzo RV (2008) Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 283:21305\u201321309. https:\/\/doi.org\/10.1074\/jbc.R800020200","journal-title":"J Biol Chem"},{"key":"4216_CR3","doi-asserted-by":"publisher","first-page":"18843","DOI":"10.1074\/jbc.274.27.18843","volume":"274","author":"RV Iozzo","year":"1999","unstructured":"Iozzo RV (1999) The biology of the small leucine-rich proteoglycans functional network of interactive proteins. J Biol Chem 274:18843\u201318846. https:\/\/doi.org\/10.1074\/jbc.274.27.18843","journal-title":"J Biol Chem"},{"key":"4216_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1369\/0022155412456380","volume":"60","author":"MV Nastase","year":"2012","unstructured":"Nastase MV, Young MF, Schaefer L (2012) Biglycan: a multivalent proteoglycan providing structure and signals. J Histochem Cytochem 60:963\u2013975. https:\/\/doi.org\/10.1369\/0022155412456380","journal-title":"J Histochem Cytochem"},{"key":"4216_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0888-7543(90)90560-H","volume":"6","author":"OW McBride","year":"1990","unstructured":"McBride OW, Fisher LW, Young MF (1990) Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively. Genomics 6:219\u2013225. https:\/\/doi.org\/10.1016\/0888-7543(90)90560-H","journal-title":"Genomics"},{"issue":"2","key":"4216_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1","volume":"38","author":"N Matsushima","year":"2000","unstructured":"Matsushima N, Ohyanagi T, Tanaka T, Kretsinger RH (2000) Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans\u2014biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin. Proteins 38(2):210\u2013225. https:\/\/doi.org\/10.1002\/(SICI)1097-0134(20000201)38:2%3c210::AID-PROT9%3e3.0.CO;2-1","journal-title":"Proteins"},{"key":"4216_CR7","doi-asserted-by":"publisher","first-page":"13324","DOI":"10.1074\/jbc.M513470200","volume":"281","author":"PG Scott","year":"2006","unstructured":"Scott PG, Dodd CM, Bergmann EM, Sheehan JK, Bishop PN (2006) Crystal structure of the biglycan dimer and evidence that dimerization is essential for folding and stability of class I small leucine-rich repeat proteoglycans. J Biol Chem 281:13324\u201313332. https:\/\/doi.org\/10.1074\/jbc.M513470200","journal-title":"J Biol Chem"},{"issue":"2","key":"4216_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jsb.2006.01.016","volume":"155","author":"PA McEwan","year":"2006","unstructured":"McEwan PA, Scott PG, Bishop PN, Bella J (2006) Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans. J Struct Biol 155(2):294\u2013305. https:\/\/doi.org\/10.1016\/j.jsb.2006.01.016","journal-title":"J Struct Biol"},{"key":"4216_CR9","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.ajpath.2011.07.026","volume":"179","author":"S Chen","year":"2011","unstructured":"Chen S, Sun M, Meng X, Iozzo RV, Kao WW, Birk DE (2011) Pathophysiological mechanisms of autosomal dominant congenital stromal corneal dystrophy: C-terminal\u2013truncated decorin results in abnormal matrix assembly and altered expression of small leucine-rich proteoglycans. Am J Pathol 179:2409\u20132419. https:\/\/doi.org\/10.1016\/j.ajpath.2011.07.026","journal-title":"Am J Pathol"},{"key":"4216_CR10","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1172\/JCI23755","volume":"115","author":"L Schaefer","year":"2005","unstructured":"Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M et al (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115:2223\u20132233. https:\/\/doi.org\/10.1172\/JCI23755","journal-title":"J Clin Invest"},{"key":"4216_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.matbio.2018.02.016","volume":"68\u201369","author":"JR Fallon","year":"2018","unstructured":"Fallon JR, McNally EM (2018) Non-glycanated biglycan and LTBP4: leveraging the extracellular matrix for Duchenne muscular dystrophy therapeutics. Matrix Biol 68\u201369:616\u2013627. https:\/\/doi.org\/10.1016\/j.matbio.2018.02.016","journal-title":"Matrix Biol"},{"issue":"1","key":"4216_CR12","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1186\/s12891-020-03650-2","volume":"21","author":"MY Pechanec","year":"2020","unstructured":"Pechanec MY, Boyd TN, Baar K, Mienaltowski MJ (2020) Adding exogenous biglycan or decorin improves tendon formation for equine peritenon and tendon proper cells in vitro. BMC Musculoskelet Disord 21(1):627. https:\/\/doi.org\/10.1186\/s12891-020-03650-2","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"4216_CR13","doi-asserted-by":"publisher","first-page":"12627","DOI":"10.1038\/s41598-017-12651-6","volume":"7","author":"V Kram","year":"2017","unstructured":"Kram V, Kilts TM, Bhattacharyya N, Li L, Young MF (2017) Small leucine rich proteoglycans, a novel link to osteoclastogenesis. Sci Rep 7(1):12627. https:\/\/doi.org\/10.1038\/s41598-017-12651-6","journal-title":"Sci Rep"},{"key":"4216_CR14","doi-asserted-by":"publisher","first-page":"409","DOI":"10.31616\/asj.2019.0217","volume":"14","author":"S Rajasekaran","year":"2020","unstructured":"Rajasekaran S, Soundararajan DCR, Tangavel C, Nayagam SM, Matchado MS, Muthurajan R et al (2020) Proteomic signature of nucleus pulposus in fetal intervertebral disc. Asian spine journal 14:409. Asian Spine J 14:409\u2013420. https:\/\/doi.org\/10.31616\/asj.2019.0217","journal-title":"Asian Spine J"},{"issue":"4","key":"4216_CR15","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/gim.2016.126","volume":"19","author":"JA Meester","year":"2017","unstructured":"Meester JA, Vandeweyer G, Pintelon I, Lammens M, Van Hoorick L, De Belder S et al (2017) Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections. Genet Med 19(4):386\u2013395. https:\/\/doi.org\/10.1038\/gim.2016.126","journal-title":"Genet Med"},{"key":"4216_CR16","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1074\/jbc.270.6.2776","volume":"270","author":"E Sch\u00f6nherr","year":"1995","unstructured":"Sch\u00f6nherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H (1995) Interaction of biglycan with type I collagen. J Biol Chem 270:2776\u20132783. https:\/\/doi.org\/10.1074\/jbc.270.6.2776","journal-title":"J Biol Chem"},{"key":"4216_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.actbio.2019.09.026","volume":"100","author":"MC McCorry","year":"2019","unstructured":"McCorry MC, Kim J, Springer NL, Sandy J, Plaas A, Bonassar LJ (2019) Regulation of proteoglycan production by varying glucose concentrations controls fiber formation in tissue engineered menisci. Acta Biomater 100:173\u2013183. https:\/\/doi.org\/10.1016\/j.actbio.2019.09.026","journal-title":"Acta Biomater"},{"key":"4216_CR18","doi-asserted-by":"publisher","first-page":"107R","DOI":"10.1093\/glycob\/cwf065","volume":"12","author":"L Ameye","year":"2002","unstructured":"Ameye L, Young MF (2002) Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 12:107R-R116. https:\/\/doi.org\/10.1093\/glycob\/cwf065","journal-title":"Glycobiology"},{"key":"4216_CR19","doi-asserted-by":"publisher","first-page":"37128","DOI":"10.1038\/srep37128","volume":"6","author":"C Mayer","year":"2016","unstructured":"Mayer C, Adam M, Glashauser L, Dietrich K, Schwarzer J, K\u00f6hn FM et al (2016) Sterile inflammation as a factor in human male infertility: Involvement of Toll like receptor 2, biglycan and peritubular cells. Sci Rep 6:37128. https:\/\/doi.org\/10.1038\/srep37128","journal-title":"Sci Rep"},{"key":"4216_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.matbio.2018.05.006","volume":"77","author":"H Roedig","year":"2019","unstructured":"Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C et al (2019) Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol 77:4\u201322. https:\/\/doi.org\/10.1016\/j.matbio.2018.05.006","journal-title":"Matrix Biol"},{"key":"4216_CR21","doi-asserted-by":"publisher","first-page":"30609","DOI":"10.1038\/srep30609","volume":"6","author":"J Kim","year":"2016","unstructured":"Kim J, Lee SK, Shin JM, Jeoun UW, Jang YJ, Park HS et al (2016) Enhanced biglycan gene expression in the adipose tissues of obese women and its association with obesity-related genes and metabolic parameters. Sci Rep 6:30609. https:\/\/doi.org\/10.1038\/srep30609","journal-title":"Sci Rep"},{"key":"4216_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2019.01.003","volume":"491","author":"S Appunni","year":"2019","unstructured":"Appunni S, Anand V, Khandelwal M, Gupta N, Rubens M, Sharma A (2019) Small leucine rich proteoglycans (decorin, biglycan and lumican) in cancer. Clin Chim Acta 491:1\u20137. https:\/\/doi.org\/10.1016\/j.cca.2019.01.003","journal-title":"Clin Chim Acta"},{"key":"4216_CR23","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.3892\/ol.2020.11266","volume":"19","author":"SF Zhao","year":"2020","unstructured":"Zhao SF, Yin XJ, Zhao WJ, Liu LC, Wang ZP (2020) Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers. Oncol Lett 19:1673\u20131682. https:\/\/doi.org\/10.3892\/ol.2020.11266","journal-title":"Oncol Lett"},{"key":"4216_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.biocel.2014.07.020","volume":"54","author":"LT Hsieh","year":"2014","unstructured":"Hsieh LT, Nastase MV, Zeng-Brouwers J, Iozzo RV, Schaefer L (2014) Soluble biglycan as a biomarker of inflammatory renal diseases. Int J Biochem Cell Biol 54:223\u2013235. https:\/\/doi.org\/10.1016\/j.biocel.2014.07.020","journal-title":"Int J Biochem Cell Biol"},{"key":"4216_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.kint.2018.12.007","volume":"95","author":"M Meissner","year":"2019","unstructured":"Meissner M, Viehmann SF, Kurts C (2019) DAMPening sterile inflammation of the kidney. Kidney Int 95:489\u2013491. https:\/\/doi.org\/10.1016\/j.kint.2018.12.007","journal-title":"Kidney Int"},{"key":"4216_CR26","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.matbio.2014.01.010","volume":"35","author":"K Moreth","year":"2014","unstructured":"Moreth K, Frey H, Hubo M, Zeng-Brouwers J, Nastase MV, Hsieh LT et al (2014) Biglycan-triggered TLR-2-and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. Matrix Biol 35:143\u2013151. https:\/\/doi.org\/10.1016\/j.matbio.2014.01.010","journal-title":"Matrix Biol"},{"key":"4216_CR27","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/ijms18030595","volume":"18","author":"LT Hsieh","year":"2017","unstructured":"Hsieh LT, Nastase MV, Roedig H, Zeng-Brouwers J, Poluzzi C, Schwalm S et al (2017) Biglycan-and sphingosine kinase-1 signaling crosstalk regulates the synthesis of macrophage chemoattractants. Int J Mol Sci 18:595. https:\/\/doi.org\/10.3390\/ijms18030595","journal-title":"Int J Mol Sci"},{"key":"4216_CR28","doi-asserted-by":"publisher","first-page":"24035","DOI":"10.1074\/jbc.M109.014266","volume":"284","author":"A Babelova","year":"2009","unstructured":"Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF et al (2009) Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors. J Biol Chem 284:24035\u201324048. https:\/\/doi.org\/10.1074\/jbc.M109.014266","journal-title":"J Biol Chem"},{"key":"4216_CR29","doi-asserted-by":"publisher","first-page":"107818","DOI":"10.1016\/j.celrep.2020.107818","volume":"31","author":"CY Han","year":"2020","unstructured":"Han CY, Kang I, Harten IA, Gebe JA, Chan CK, Omer M et al (2020) Adipocyte-derived versican and macrophage-derived biglycan control adipose tissue inflammation in obesity. Cell Rep 31:107818. https:\/\/doi.org\/10.1016\/j.celrep.2020.107818","journal-title":"Cell Rep"},{"key":"4216_CR30","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.kint.2018.10.037","volume":"95","author":"C Poluzzi","year":"2019","unstructured":"Poluzzi C, Nastase MV, Zeng-Brouwers J, Roedig H, Hsieh LT, Michaelis JB et al (2019) Biglycan evokes autophagy in macrophages via a novel CD44\/Toll-like receptor 4 signaling axis in ischemia\/reperfusion injury. Kidney Int 95:540\u2013562. https:\/\/doi.org\/10.1016\/j.kint.2018.10.037","journal-title":"Kidney Int"},{"key":"4216_CR31","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.matbio.2017.12.002","volume":"68\u201369","author":"MV Nastase","year":"2018","unstructured":"Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH et al (2018) Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol 68\u201369:293\u2013317. https:\/\/doi.org\/10.1016\/j.matbio.2017.12.002","journal-title":"Matrix Biol"},{"key":"4216_CR32","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1172\/JCI42213","volume":"120","author":"K Moreth","year":"2010","unstructured":"Moreth K, Brodbeck R, Babelova A, Gretz N, Spieker T, Zeng-Brouwers J et al (2010) The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis. J Clin Invest 120:4251\u20134272. https:\/\/doi.org\/10.1172\/JCI42213","journal-title":"J Clin Invest"},{"key":"4216_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lfs.2019.05.047","volume":"230","author":"P Sun","year":"2019","unstructured":"Sun P, Ye R, Wang C, Bai S, Zhao L (2019) Identification of proteomic signatures associated with COPD frequent exacerbators. Life Sci 230:1\u20139. https:\/\/doi.org\/10.1016\/j.lfs.2019.05.047","journal-title":"Life Sci"},{"key":"4216_CR34","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/ATVBAHA.115.306973","volume":"36","author":"M Grandoch","year":"2016","unstructured":"Grandoch M, Kohlmorgen C, Melchior-Becker A, Feldmann K, Homann S, M\u00fcller J et al (2016) Loss of biglycan enhances thrombin generation in apolipoprotein E-deficient mice: implications for inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 36:e41-50. https:\/\/doi.org\/10.1161\/ATVBAHA.115.306973","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4216_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/1354750X.2018.1548032","volume":"24","author":"AS Siebuhr","year":"2019","unstructured":"Siebuhr AS, Juhl P, Bay-Jensen AC, Karsdal MA, Franchimont N, Chavez JC (2019) Citrullinated vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: a pilot study. Biomarkers 24:249\u2013254. https:\/\/doi.org\/10.1080\/1354750X.2018.1548032","journal-title":"Biomarkers"},{"key":"4216_CR36","first-page":"301","volume":"20","author":"R Hesselstrand","year":"2002","unstructured":"Hesselstrand R, Westergren-Thorsson G, Scheja A, Wildt M, Akesson A (2002) The association between changes in skin echogenicity and the fibroblast production of biglycan and versican in systemic sclerosis. Clin Exp Rheumatol 20:301\u2013308","journal-title":"Clin Exp Rheumatol"},{"key":"4216_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41443-017-0015-1","volume":"30","author":"DJ Cohen","year":"2018","unstructured":"Cohen DJ, Oliveira AV, Theodoro TR, Petri G, Melo CM, Cavalheiro RP et al (2018) Extracellular matrix alterations after blood instillation in tunica albuginea of rats. Int J Impot Res 30:85\u201392. https:\/\/doi.org\/10.1038\/s41443-017-0015-1","journal-title":"Int J Impot Res"},{"key":"4216_CR38","doi-asserted-by":"publisher","first-page":"100178","DOI":"10.1016\/j.jhepr.2020.100178","volume":"3","author":"M Vesterhus","year":"2021","unstructured":"Vesterhus M, Nielsen MJ, Hov JR, Saffioti F, Manon-Jensen T, Leeming DJ et al (2021) Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease. JHEP Rep 3:100178. https:\/\/doi.org\/10.1016\/j.jhepr.2020.100178","journal-title":"JHEP Rep"},{"key":"4216_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jim-2018-000840","volume":"67","author":"A Sobhy","year":"2019","unstructured":"Sobhy A, Azeem HA, Ashmawy AM, Khalifa HO (2019) Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus. J Investig Med 67:681\u2013685. https:\/\/doi.org\/10.1136\/jim-2018-000840","journal-title":"J Investig Med"},{"key":"4216_CR40","doi-asserted-by":"publisher","first-page":"e22109","DOI":"10.1002\/jcla.22109","volume":"31","author":"R Ciftciler","year":"2017","unstructured":"Ciftciler R, Ozenirler S, Yucel AA, Cengiz M, Erkan G, Buyukdemirci E et al (2017) The importance of serum biglycan levels as a fibrosis marker in patients with chronic hepatitis B. J Clin Lab Anal 31:e22109. https:\/\/doi.org\/10.1002\/jcla.22109","journal-title":"J Clin Lab Anal"},{"key":"4216_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/infdis\/jiz050","volume":"220","author":"J Cuellar","year":"2019","unstructured":"Cuellar J, Pietik\u00e4inen A, Glader O, Liljenb\u00e4ck H, S\u00f6derstr\u00f6m M, Hurme S et al (2019) Borrelia burgdorferi infection in biglycan knockout mice. J Infect Dis 220:116\u2013126. https:\/\/doi.org\/10.1093\/infdis\/jiz050","journal-title":"J Infect Dis"},{"key":"4216_CR42","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.1016\/j.bbadis.2018.10.002","volume":"1864","author":"Z Ying","year":"2018","unstructured":"Ying Z, Byun HR, Meng Q, Noble E, Zhang G, Yang X et al (2018) Biglycan gene connects metabolic dysfunction with brain disorder. Biochim Biophys Acta Mol Basis Dis 1864:3679\u20133687. https:\/\/doi.org\/10.1016\/j.bbadis.2018.10.002","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4216_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1476-9255-9-15","volume":"9","author":"VJ Adapala","year":"2012","unstructured":"Adapala VJ, Ward M, Ajuwon KM (2012) Adipose tissue biglycan as a potential anti-inflammatory target of sodium salicylate in mice fed a high fat diet. J Inflamm (Lond) 9:15. https:\/\/doi.org\/10.1186\/1476-9255-9-15","journal-title":"J Inflamm (Lond)"},{"key":"4216_CR44","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3389\/fimmu.2020.01800","volume":"11","author":"V Peek","year":"2020","unstructured":"Peek V, Neumann E, Inoue T, Koenig S, Pflieger FJ, Gerstberger R et al (2020) Age-dependent changes of adipokine and cytokine secretion from rat adipose tissue by endogenous and exogenous toll-like receptor agonists. Front Immunol 11:1800. https:\/\/doi.org\/10.3389\/fimmu.2020.01800","journal-title":"Front Immunol"},{"key":"4216_CR45","doi-asserted-by":"publisher","first-page":"e003434","DOI":"10.1161\/JAHA.112.003434","volume":"1","author":"R Mangat","year":"2012","unstructured":"Mangat R, Warnakula S, Borthwick F, Hassanali Z, Uwiera RR, Russell JC et al (2012) Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR: LA-cp rat. J Am Heart Assoc 1:e003434. https:\/\/doi.org\/10.1161\/JAHA.112.003434","journal-title":"J Am Heart Assoc"},{"key":"4216_CR46","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1161\/ATVBAHA.111.226159","volume":"31","author":"T Chiba","year":"2011","unstructured":"Chiba T, Chang MY, Wang S, Wight TN, McMillen TS, Oram JF et al (2011) Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans. Arterioscler Thromb Vasc Biol 31:1326\u20131332. https:\/\/doi.org\/10.1161\/ATVBAHA.111.226159","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4216_CR47","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.2337\/db09-0206","volume":"58","author":"A Hiukka","year":"2009","unstructured":"Hiukka A, St\u00e5hlman M, Pettersson C, Levin M, Adiels M, Teneberg S et al (2009) ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition, increased susceptibility for sphingomyelinase, and increased binding to biglycan. Diabetes 58:2018\u20132026. https:\/\/doi.org\/10.2337\/db09-0206","journal-title":"Diabetes"},{"key":"4216_CR48","doi-asserted-by":"publisher","first-page":"158545","DOI":"10.1016\/j.bbalip.2019.158545","volume":"1865","author":"M Scuruchi","year":"2020","unstructured":"Scuruchi M, Pot\u00ec F, Rodr\u00edguez-Carrio J, Campo GM, Mandraffino G (2020) Biglycan and atherosclerosis: lessons from high cardiovascular risk conditions. Biochim Biophys Acta Mol Cell Biol Lipids 1865:158545. https:\/\/doi.org\/10.1016\/j.bbalip.2019.158545","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"4216_CR49","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1194\/jlr.M078204","volume":"58","author":"PG Wilson","year":"2017","unstructured":"Wilson PG, Thompson JC, Yoder MH, Charnigo R, Tannock LR (2017) Prevention of renal apoB retention is protective against diabetic nephropathy: role of TGF-\u03b2 inhibition. J Lipid Res 58:2264\u20132274. https:\/\/doi.org\/10.1194\/jlr.M078204","journal-title":"J Lipid Res"},{"key":"4216_CR50","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.atherosclerosis.2014.03.037","volume":"235","author":"JC Thompson","year":"2014","unstructured":"Thompson JC, Tang T, Wilson PG, Yoder MH, Tannock LR (2014) Increased atherosclerosis in mice with increased vascular biglycan content. Atherosclerosis 235:71\u201375. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.03.037","journal-title":"Atherosclerosis"},{"key":"4216_CR51","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/1479164118817922","volume":"16","author":"M Barth","year":"2019","unstructured":"Barth M, Selig JI, Klose S, Schomakers A, Kiene LS, Raschke S et al (2019) Degenerative aortic valve disease and diabetes: Implications for a link between proteoglycans and diabetic disorders in the aortic valve. Diab Vasc Dis Res 16:254\u2013269. https:\/\/doi.org\/10.1177\/1479164118817922","journal-title":"Diab Vasc Dis Res"},{"key":"4216_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2013.12.038","volume":"233","author":"EB Neufeld","year":"2014","unstructured":"Neufeld EB, Zadrozny LM, Phillips D, Aponte A, Yu ZX, Balaban RS (2014) Decorin and biglycan retain LDL in disease-prone valvular and aortic subendothelial intimal matrix. Atherosclerosis 233:113\u2013121. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.12.038","journal-title":"Atherosclerosis"},{"key":"4216_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00109-014-1229-z","volume":"93","author":"R Song","year":"2015","unstructured":"Song R, Fullerton DA, Ao L, Zheng D, Zhao KS, Meng X (2015) BMP-2 and TGF-\u03b21 mediate biglycan-induced pro-osteogenic reprogramming in aortic valve interstitial cells. J Mol Med (Berl) 93:403\u2013412. https:\/\/doi.org\/10.1007\/s00109-014-1229-z","journal-title":"J Mol Med (Berl)"},{"key":"4216_CR54","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.yjmcc.2014.07.014","volume":"75","author":"T Tang","year":"2014","unstructured":"Tang T, Thompson JC, Wilson PG, Yoder MH, M\u00fceller J, Fischer JW et al (2014) Biglycan deficiency: increased aortic aneurysm formation and lack of atheroprotection. J Mol Cell Cardiol 75:174\u2013180. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.07.014","journal-title":"J Mol Cell Cardiol"},{"key":"4216_CR55","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.atherosclerosis.2014.10.024","volume":"237","author":"G Mandraffino","year":"2014","unstructured":"Mandraffino G, Imbalzano E, Mamone F, Aragona C, Gullo AL, D\u2019Ascola A et al (2014) Biglycan expression in current cigarette smokers: a possible link between active smoking and atherogenesis. Atherosclerosis 237:471\u2013479. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.10.024","journal-title":"Atherosclerosis"},{"key":"4216_CR56","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2017.01.012","volume":"257","author":"G Mandraffino","year":"2017","unstructured":"Mandraffino G, Aragona CO, Scuruchi M, Mamone F, D\u2019Ascola A, Alibrandi A et al (2017) Biglycan expression, earlier vascular damage and pro-atherogenic profile improvement after smoke cessation in young people. Atherosclerosis 257:109\u2013115. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.01.012","journal-title":"Atherosclerosis"},{"key":"4216_CR57","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2009.05.024","volume":"406","author":"MA Sardo","year":"2009","unstructured":"Sardo MA, Mandraffino G, Campo S, Saitta C, Bitto A, Alibrandi A et al (2009) Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness. Clin Chim Acta 406:89\u201393. https:\/\/doi.org\/10.1016\/j.cca.2009.05.024","journal-title":"Clin Chim Acta"},{"key":"4216_CR58","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/j.1440-1681.2010.05407.x","volume":"37","author":"MA Sardo","year":"2010","unstructured":"Sardo MA, Mandraffino G, Riggio S, D\u2019Ascola A, Alibrandi A, Saitta C et al (2010) Effects of the angiotensin II receptor blocker losartan on the monocyte expression of biglycan in hypertensive patients. Clin Exp Pharmacol Physiol 37:933\u2013938. https:\/\/doi.org\/10.1111\/j.1440-1681.2010.05407.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4216_CR59","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1161\/CIRCULATIONAHA.106.653980","volume":"115","author":"AM Heegaard","year":"2007","unstructured":"Heegaard AM, Corsi A, Danielsen CC, Nielsen KL, Jorgensen HL, Riminucci M et al (2007) Biglycan deficiency causes spontaneous aortic dissection and rupture in mice. Circulation 115:2731\u20132738. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.653980","journal-title":"Circulation"},{"key":"4216_CR60","doi-asserted-by":"publisher","first-page":"L1327","DOI":"10.1152\/ajplung.2001.280.6.L1327","volume":"280","author":"M Kolb","year":"2001","unstructured":"Kolb M, Margetts PJ, Sime PJ, Gauldie J (2001) Proteoglycans decorin and biglycan differentially modulate TGF-\u03b2-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 280:L1327-1334. https:\/\/doi.org\/10.1152\/ajplung.2001.280.6.L1327","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4216_CR61","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2017.11.005","volume":"268","author":"JC Thompson","year":"2018","unstructured":"Thompson JC, Wilson PG, Wyllie AP, Wyllie AK, Tannock LR (2018) Elevated circulating TGF-\u03b2 is not the cause of increased atherosclerosis development in biglycan deficient mice. Atherosclerosis 268:68\u201375. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.11.005","journal-title":"Atherosclerosis"},{"key":"4216_CR62","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ebiom.2016.04.008","volume":"7","author":"Q Meng","year":"2016","unstructured":"Meng Q, Ying Z, Noble E, Zhao Y, Agrawal R, Mikhail A et al (2016) Systems nutrigenomics reveals brain gene networks linking metabolic and brain disorders. EBioMedicine 7:157\u2013166. https:\/\/doi.org\/10.1016\/j.ebiom.2016.04.008","journal-title":"EBioMedicine"},{"key":"4216_CR63","doi-asserted-by":"publisher","first-page":"101042831769911","DOI":"10.1177\/1010428317699112","volume":"39","author":"S Appunni","year":"2017","unstructured":"Appunni S, Anand V, Khandelwal M, Seth A, Mathur S, Sharma A (2017) Altered expression of small leucine-rich proteoglycans (Decorin, Biglycan and Lumican): plausible diagnostic marker in urothelial carcinoma of bladder. Tumour Biol 39:1010428317699112. https:\/\/doi.org\/10.1177\/1010428317699112","journal-title":"Tumour Biol"},{"key":"4216_CR64","doi-asserted-by":"publisher","first-page":"28039","DOI":"10.1038\/srep28039","volume":"6","author":"N Maishi","year":"2016","unstructured":"Maishi N, Ohba Y, Akiyama K, Ohga N, Hamada J, Nagao-Kitamoto H et al (2016) Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan. Sci Rep 6:28039. https:\/\/doi.org\/10.1038\/srep28039","journal-title":"Sci Rep"},{"key":"4216_CR65","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fonc.2018.00470","volume":"8","author":"J Aggelidakis","year":"2018","unstructured":"Aggelidakis J, Berdiaki A, Nikitovic D, Papoutsidakis A, Papachristou DJ, Tsatsakis AM et al (2018) Biglycan regulates MG63 osteosarcoma cell growth through a LPR6\/\u03b2-catenin\/IGFR-IR signaling axis. Front Oncol 8:470. https:\/\/doi.org\/10.3389\/fonc.2018.00470","journal-title":"Front Oncol"},{"key":"4216_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.matbio.2020.09.002","volume":"94","author":"R Hua","year":"2020","unstructured":"Hua R, Ni Q, Eliason TD, Han Y, Gu S, Nicolella DP et al (2020) Biglycan and chondroitin sulfate play pivotal roles in bone toughness via retaining bound water in bone mineral matrix. Matrix Biol 94:95\u2013109. https:\/\/doi.org\/10.1016\/j.matbio.2020.09.002","journal-title":"Matrix Biol"},{"key":"4216_CR67","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10555-020-09887-6","volume":"39","author":"Z Zhong","year":"2020","unstructured":"Zhong Z, Yu J, Virshup DM, Madan B (2020) Wnts and the hallmarks of cancer. Cancer Metastasis Rev 39:625\u2013645. https:\/\/doi.org\/10.1007\/s10555-020-09887-6","journal-title":"Cancer Metastasis Rev"},{"key":"4216_CR68","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.1038\/s41598-017-05280-6","volume":"7","author":"H Li","year":"2017","unstructured":"Li H, Zhong A, Li S, Meng X, Wang X, Xu F et al (2017) The integrated pathway of TGF\u03b2\/Snail with TNF\u03b1\/NF\u03baB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis. Sci Rep 7:4915. https:\/\/doi.org\/10.1038\/s41598-017-05280-6","journal-title":"Sci Rep"},{"key":"4216_CR69","doi-asserted-by":"publisher","first-page":"6639","DOI":"10.12659\/MSM.915075","volume":"25","author":"D Fang","year":"2019","unstructured":"Fang D, Lai Z, Wang Y (2019) Overexpression of biglycan is associated with resistance to rapamycin in human WERI-Rb-1 retinoblastoma cells by inducing the activation of the phosphatidylinositol 3-kinases (PI3K)\/Akt\/nuclear factor kappa B (NF-\u03baB) signaling pathway. Med Sci Monit 25:6639\u20136648. https:\/\/doi.org\/10.12659\/MSM.915075","journal-title":"Med Sci Monit"},{"key":"4216_CR70","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10529-020-02818-z","volume":"42","author":"S Chen","year":"2020","unstructured":"Chen S, Guo D, Lei B, Bi J, Yang H (2020) Biglycan protects human neuroblastoma cells from nitric oxide-induced death by inhibiting AMPK-mTOR mediated autophagy and intracellular ROS level. Biotechnol Lett 42:657\u2013668. https:\/\/doi.org\/10.1007\/s10529-020-02818-z","journal-title":"Biotechnol Lett"},{"key":"4216_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.semcancer.2019.07.026","volume":"62","author":"H Roedig","year":"2020","unstructured":"Roedig H, Damiescu R, Zeng-Brouwers J, Kutija I, Trebicka J, Wygrecka M et al (2020) Danger matrix molecules orchestrate CD14\/CD44 signaling in cancer development. Semin Cancer Biol 62:31\u201347. https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.026","journal-title":"Semin Cancer Biol"},{"key":"4216_CR72","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/bjc.2012.59","volume":"106","author":"K Yamamoto","year":"2012","unstructured":"Yamamoto K, Ohga N, Hida Y, Maishi N, Kawamoto T, Kitayama K et al (2012) Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells. Br J Cancer 106:1214\u20131223. https:\/\/doi.org\/10.1038\/bjc.2012.59","journal-title":"Br J Cancer"},{"key":"4216_CR73","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.molonc.2016.08.002","volume":"10","author":"L Hu","year":"2016","unstructured":"Hu L, Zang MD, Wang HX, Li JF, Su LP, Yan M (2016) Biglycan stimulates VEGF expression in endothelial cells by activating the TLR signaling pathway. Mol Oncol 10:1473\u20131484. https:\/\/doi.org\/10.1016\/j.molonc.2016.08.002","journal-title":"Mol Oncol"},{"key":"4216_CR74","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/cas.13336","volume":"108","author":"N Maishi","year":"2017","unstructured":"Maishi N, Hida K (2017) Tumor endothelial cells accelerate tumor metastasis. Cancer Sci 108:1921\u20131926. https:\/\/doi.org\/10.1111\/cas.13336","journal-title":"Cancer Sci"},{"key":"4216_CR75","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.3892\/mmr.2015.4383","volume":"12","author":"X Xing","year":"2015","unstructured":"Xing X, Gu X, Ma T (2015) Knockdown of biglycan expression by RNA interference inhibits the proliferation and invasion of, and induces apoptosis in, the HCT116 colon cancer cell line. Mol Med Rep 12:7538\u20137544. https:\/\/doi.org\/10.3892\/mmr.2015.4383","journal-title":"Mol Med Rep"},{"key":"4216_CR76","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.18632\/oncotarget.1871","volume":"5","author":"L Hu","year":"2014","unstructured":"Hu L, Duan YT, Li JF, Su LP, Yan M, Zhu ZG et al (2014) Biglycan enhances gastric cancer invasion by activating FAK signaling pathway. Oncotarget 5:1885\u20131896. https:\/\/doi.org\/10.18632\/oncotarget.1871","journal-title":"Oncotarget"},{"key":"4216_CR77","doi-asserted-by":"publisher","first-page":"5716","DOI":"10.3390\/ijms20225716","volume":"20","author":"D Guo","year":"2019","unstructured":"Guo D, Zhang W, Yang H, Bi J, Xie Y, Cheng B et al (2019) Celastrol induces necroptosis and ameliorates inflammation via targeting biglycan in human gastric carcinoma. Int J Mol Sci 20:5716. https:\/\/doi.org\/10.3390\/ijms20225716","journal-title":"Int J Mol Sci"},{"key":"4216_CR78","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s11010-018-3365-1","volume":"449","author":"B Liu","year":"2018","unstructured":"Liu B, Xu T, Xu X, Cui Y, Xing X (2018) Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-\u03baB signal transduction. Mol Cell Biochem 449:285\u2013294. https:\/\/doi.org\/10.1007\/s11010-018-3365-1","journal-title":"Mol Cell Biochem"},{"key":"4216_CR79","doi-asserted-by":"publisher","first-page":"153303382096423","DOI":"10.1177\/1533033820964238","volume":"20","author":"T Ruan","year":"2021","unstructured":"Ruan T, Lu S, Xu J, Zhou JY (2021) lncRNA LINC00460 Functions as a competing endogenous RNA and regulates expression of BGN by sponging miR-149-5p in colorectal cancer. Technol Cancer Res Treat 20:1533033820964238. https:\/\/doi.org\/10.1177\/1533033820964238","journal-title":"Technol Cancer Res Treat"},{"key":"4216_CR80","doi-asserted-by":"publisher","first-page":"530.e9","DOI":"10.1016\/j.urolonc.2019.05.011","volume":"37","author":"GB Schulz","year":"2019","unstructured":"Schulz GB, Grimm T, Sers C, Riemer P, Elmasry M, Kirchner T et al (2019) Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer. Urol Oncol 37:530.e9-530.e18. https:\/\/doi.org\/10.1016\/j.urolonc.2019.05.011","journal-title":"Urol Oncol"},{"key":"4216_CR81","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.18632\/oncotarget.27674","volume":"11","author":"R Fujiwara-Tani","year":"2020","unstructured":"Fujiwara-Tani R, Sasaki T, Fujii K, Luo Y, Mori T, Kishi S et al (2020) Diabetes mellitus is associated with liver metastasis of colorectal cancer through production of biglycan-rich cancer stroma. Oncotarget 11:2982\u20132994. https:\/\/doi.org\/10.18632\/oncotarget.27674","journal-title":"Oncotarget"},{"key":"4216_CR82","doi-asserted-by":"publisher","first-page":"42901","DOI":"10.18632\/oncotarget.17160","volume":"8","author":"H Andrlov\u00e1","year":"2017","unstructured":"Andrlov\u00e1 H, Mastroianni J, Madl J, Kern JS, Melchinger W, Dierbach H et al (2017) Biglycan expression in the melanoma microenvironment promotes invasiveness via increased tissue stiffness inducing integrin-\u03b21 expression. Oncotarget 8:42901\u201342916. https:\/\/doi.org\/10.18632\/oncotarget.17160","journal-title":"Oncotarget"},{"key":"4216_CR83","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.neo.2017.06.003","volume":"19","author":"F Jacobsen","year":"2017","unstructured":"Jacobsen F, Kraft J, Schroeder C, Hube-Magg C, Kluth M, Lang DS et al (2017) Up-regulation of biglycan is associated with poor prognosis and PTEN deletion in patients with prostate cancer. Neoplasia 19:707\u2013715. https:\/\/doi.org\/10.1016\/j.neo.2017.06.003","journal-title":"Neoplasia"},{"key":"4216_CR84","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","volume":"96","author":"DG Allen","year":"2016","unstructured":"Allen DG, Whitehead NP, Froehner SC (2016) Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev 96:253\u2013305. https:\/\/doi.org\/10.1152\/physrev.00007.2015","journal-title":"Physiol Rev"},{"key":"4216_CR85","doi-asserted-by":"publisher","first-page":"965631","DOI":"10.1155\/2014\/965631","volume":"2014","author":"Y Kharraz","year":"2014","unstructured":"Kharraz Y, Guerra J, Pessina P, Serrano AL, Mu\u00f1oz-C\u00e1noves P (2014) Understanding the process of fibrosis in Duchenne muscular dystrophy. Biomed Res Int 2014:965631. https:\/\/doi.org\/10.1155\/2014\/965631","journal-title":"Biomed Res Int"},{"key":"4216_CR86","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1089\/hum.2015.088","volume":"28","author":"M Ito","year":"2017","unstructured":"Ito M, Ehara Y, Li J, Inada K, Ohno K (2017) Protein-anchoring therapy of biglycan for Mdx Mouse Model of Duchenne muscular dystrophy. Hum Gene Ther 28:428\u2013436. https:\/\/doi.org\/10.1089\/hum.2015.088","journal-title":"Hum Gene Ther"},{"key":"4216_CR87","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1073\/pnas.1013067108","volume":"108","author":"AR Amenta","year":"2011","unstructured":"Amenta AR, Yilmaz A, Bogdanovich S, McKechnie BA, Abedi M, Khurana TS et al (2011) Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice. Proc Natl Acad Sci USA 108:762\u2013767. https:\/\/doi.org\/10.1073\/pnas.1013067108","journal-title":"Proc Natl Acad Sci USA"},{"key":"4216_CR88","doi-asserted-by":"publisher","DOI":"10.1080\/03008207.2019.1694011","author":"LR Smith","year":"2021","unstructured":"Smith LR, Pichika R, Meza RC, Gillies AR, Baliki MN, Chambers HG et al (2021) Contribution of extracellular matrix components to the stiffness of skeletal muscle contractures in patients with cerebral palsy. Connect Tissue Res. https:\/\/doi.org\/10.1080\/03008207.2019.1694011","journal-title":"Connect Tissue Res"},{"key":"4216_CR89","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10719-019-09889-9","volume":"36","author":"M Wang","year":"2019","unstructured":"Wang M, Xue S, Fang Q, Zhang M, He Y, Zhang Y et al (2019) Expression and localization of the small proteoglycans decorin and biglycan in articular cartilage of Kashin-Beck disease and rats induced by T-2 toxin and selenium deficiency. Glycoconj J 36:451\u2013459. https:\/\/doi.org\/10.1007\/s10719-019-09889-9","journal-title":"Glycoconj J"},{"key":"4216_CR90","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.abb.2018.01.007","volume":"640","author":"A Avenoso","year":"2018","unstructured":"Avenoso A, D\u2019Ascola A, Scuruchi M, Mandraffino G, Calatroni A, Saitta A et al (2018) The proteoglycan biglycan mediates inflammatory response by activating TLR-4 in human chondrocytes: Inhibition by specific siRNA and high polymerized Hyaluronan. Arch Biochem Biophys 640:75\u201382. https:\/\/doi.org\/10.1016\/j.abb.2018.01.007","journal-title":"Arch Biochem Biophys"},{"key":"4216_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-015-0902-0","volume":"17","author":"G Barreto","year":"2015","unstructured":"Barreto G, Soininen A, Ylinen P, Sandelin J, Konttinen YT, Nordstr\u00f6m DC et al (2015) Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritis. Arthritis Res Ther 17:1\u201315. https:\/\/doi.org\/10.1186\/s13075-015-0902-0","journal-title":"Arthritis Res Ther"},{"key":"4216_CR92","doi-asserted-by":"publisher","first-page":"e0215830","DOI":"10.1371\/journal.pone.0215830","volume":"14","author":"AS Tsang","year":"2019","unstructured":"Tsang AS, Dart AJ, Biasutti SA, Jeffcott LB, Smith MM, Little CB (2019) Effects of tendon injury on uninjured regional tendons in the distal limb: an in-vivo study using an ovine tendinopathy model. PLoS ONE 14:e0215830. https:\/\/doi.org\/10.1371\/journal.pone.0215830","journal-title":"PLoS ONE"},{"key":"4216_CR93","doi-asserted-by":"publisher","first-page":"15898","DOI":"10.1002\/jcp.28247","volume":"234","author":"YJ Zhang","year":"2019","unstructured":"Zhang YJ, Qing Q, Zhang YJ, Ning LJ, Cui J, Yao X et al (2019) Enhancement of tenogenic differentiation of rat tendon-derived stem cells by biglycan. J Cell Physiol 234:15898\u201315910. https:\/\/doi.org\/10.1002\/jcp.28247","journal-title":"J Cell Physiol"},{"key":"4216_CR94","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.actbio.2019.03.046","volume":"93","author":"MC Schneider","year":"2019","unstructured":"Schneider MC, Chu S, Randolph MA, Bryant SJ (2019) An in vitro and in vivo comparison of cartilage growth in chondrocyte-laden matrix metalloproteinase-sensitive poly (ethylene glycol) hydrogels with localized transforming growth factor \u03b23. Acta Biomater 93:97\u2013110. https:\/\/doi.org\/10.1016\/j.actbio.2019.03.046","journal-title":"Acta Biomater"},{"key":"4216_CR95","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1096\/fj.01-0848com","volume":"16","author":"L Ameye","year":"2002","unstructured":"Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF (2002) Abnormal collagen fibrils in tendons of biglycan\/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB 16:673\u2013680. https:\/\/doi.org\/10.1096\/fj.01-0848com","journal-title":"FASEB"},{"key":"4216_CR96","doi-asserted-by":"publisher","first-page":"107627","DOI":"10.1016\/j.jsb.2020.107627","volume":"212","author":"V Kram","year":"2020","unstructured":"Kram V, Jani P, Kilts TM, Li L, Chu EY et al (2020) OPG-Fc treatment partially rescues low bone mass phenotype in mature Bgn\/Fmod deficient mice but is deleterious to the young mouse skeleton. J Struct Biol 212:107627. https:\/\/doi.org\/10.1016\/j.jsb.2020.107627","journal-title":"J Struct Biol"},{"key":"4216_CR97","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1210\/en.2004-1583","volume":"146","author":"S Morony","year":"2005","unstructured":"Morony S, Warmington K, Adamu S, Asuncion F, Geng Z, Grisanti M et al (2005) The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy. Endocrinology 146:3235\u20133243. https:\/\/doi.org\/10.1210\/en.2004-1583","journal-title":"Endocrinology"},{"key":"4216_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.matbio.2016.03.008","volume":"52","author":"M Myren","year":"2016","unstructured":"Myren M, Kirby DJ, Noonan ML, Maeda A, Owens RT, Ricard-Blum S et al (2016) Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin. Matrix Biol 52:141\u2013150. https:\/\/doi.org\/10.1016\/j.matbio.2016.03.008","journal-title":"Matrix Biol"},{"key":"4216_CR99","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.ajhg.2016.04.004","volume":"98","author":"SY Cho","year":"2016","unstructured":"Cho SY, Bae JS, Kim NK, Forzano F, Girisha KM, Baldo C et al (2016) BGN mutations in X-linked spondyloepimetaphyseal dysplasia. Am J Hum Genet 98:1243\u20131248. https:\/\/doi.org\/10.1016\/j.ajhg.2016.04.004","journal-title":"Am J Hum Genet"},{"key":"4216_CR100","doi-asserted-by":"publisher","first-page":"111506","DOI":"10.1016\/j.msec.2020.111506","volume":"119","author":"S Chen","year":"2021","unstructured":"Chen S, Wang J, Chen Y, Mo X, Fan C (2021) Tenogenic adipose-derived stem cell sheets with nanoyarn scaffolds for tendon regeneration. Mater Sci Eng C Mater Biol Appl 119:111506. https:\/\/doi.org\/10.1016\/j.msec.2020.111506","journal-title":"Mater Sci Eng C Mater Biol Appl"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04216-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04216-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04216-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T15:05:06Z","timestamp":1632668706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04216-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4216"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04216-z","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"24 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflicts of interest relevant to this article were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}